Document is current
Any future updates will be listed below
-
Authors
Reed, Steven J.
Sharma, Shibbu
Novák, Carrie
Kim, Jiho
Kim, Kaman
Niemi, Erene
Korjeff, Nicholas
Lieber, André
Reed, Steven G.
Duthie, Malcolm S.
Carter, Darrick
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 2 March 2026
First Online: 7 March 2026
Declarations
:
: HDT Bio Corp. holds a license for the JO-4 technology and is assisting in its clinical development. KK, NK, and EN are employees of Astellas. Astellas funded the research. SJR, CN, SS, AL, SGR, MSD, and DC hold shares in HDT Bio Corp.
